185 related articles for article (PubMed ID: 32810362)
21. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
[TBL] [Abstract][Full Text] [Related]
22. Combined Administration of Bisphosphonates, Chemotherapeutic Agents, and/or Targeted Drugs Increases the Risk for Stage 3 Medication-Related Osteonecrosis of the Jaw: A 4-Year Retrospective Study.
Zhou Y; Yu Y; Shi Y; Li M; Yang C; Wang S
Biomed Res Int; 2020; 2020():5847429. PubMed ID: 33123580
[TBL] [Abstract][Full Text] [Related]
23. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
[TBL] [Abstract][Full Text] [Related]
24. A technique for the treatment of oral-antral fistulas resulting from medication-related osteonecrosis of the maxilla: the combined buccal fat pad flap and radical sinusotomy.
Melville JC; Tursun R; Shum JW; Young S; Hanna IA; Marx RE
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):287-91. PubMed ID: 27307069
[TBL] [Abstract][Full Text] [Related]
25. The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study.
Yüce MO; Adalı E; Işık G
Clin Oral Investig; 2021 Jul; 25(7):4529-4541. PubMed ID: 33392802
[TBL] [Abstract][Full Text] [Related]
26. Medication-related osteonecrosis of the jaw: An institution's experience.
Altay MA; Radu A; Pack SE; Yıldırımyan N; Flores-Hidalgo A; Baur DA; Quereshy FA
Cranio; 2020 Sep; 38(5):333-341. PubMed ID: 30296919
[TBL] [Abstract][Full Text] [Related]
27. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
28. Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).
Nica DF; Riviș M; Roi CI; Todea CD; Duma VF; Sinescu C
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562600
[No Abstract] [Full Text] [Related]
29. Etiology and clinical characteristics of symptomatic unilateral maxillary sinusitis: A review of 174 cases.
Troeltzsch M; Pache C; Troeltzsch M; Kaeppler G; Ehrenfeld M; Otto S; Probst F
J Craniomaxillofac Surg; 2015 Oct; 43(8):1522-9. PubMed ID: 26319958
[TBL] [Abstract][Full Text] [Related]
30. How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?
Moreno Rabie C; García-Larraín S; Contreras Diez de Medina D; Cabello-Salazar I; Fontenele RC; Van den Wyngaert T; Jacobs R
Dentomaxillofac Radiol; 2023 Nov; 52(8):20230304. PubMed ID: 37870051
[TBL] [Abstract][Full Text] [Related]
31. Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Mast G; Otto S; Mücke T; Schreyer C; Bissinger O; Kolk A; Wolff KD; Ehrenfeld M; Stürzenbaum SR; Pautke C
J Craniomaxillofac Surg; 2012 Oct; 40(7):568-71. PubMed ID: 22118926
[TBL] [Abstract][Full Text] [Related]
32. Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study.
Kim HY; Jung YS; Park W; Choi YJ; Kim JY
BMC Oral Health; 2024 Feb; 24(1):160. PubMed ID: 38302952
[TBL] [Abstract][Full Text] [Related]
33. Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study.
Giudice A; Barone S; Diodati F; Antonelli A; Nocini R; Cristofaro MG
J Oral Maxillofac Surg; 2020 Nov; 78(11):1986-1999. PubMed ID: 32615096
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review.
Yamada SI; Kurita H; Kondo E; Suzuki S; Nishimaki F; Yoshimura N; Morioka M; Ishii S; Kamata T
Clin Oral Investig; 2019 Aug; 23(8):3203-3211. PubMed ID: 30406491
[TBL] [Abstract][Full Text] [Related]
35. Mechanism, prevention, and treatment for medication-related osteonecrosis of the jaws.
Pan J; Liu JY
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Jun; 39(3):245-254. PubMed ID: 34041871
[TBL] [Abstract][Full Text] [Related]
36. Surgical Management of Medication-Related Osteonecrosis of the Jaw Patients Related to Dental Implants.
Nisi M; Izzetti R; Gennai S; Bellini P; Graziani F; Gabriele M
J Craniofac Surg; 2020 Jun; 31(4):1037-1041. PubMed ID: 32102027
[TBL] [Abstract][Full Text] [Related]
37. Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.
Coropciuc RG; Grisar K; Aerden T; Schol M; Schoenaers J; Politis C
Br J Oral Maxillofac Surg; 2017 Oct; 55(8):787-792. PubMed ID: 28760314
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of bone perfusion through cortical perforations to improve healing of medication-related osteonecrosis of the jaw: a retrospective study.
Guo Y; Guo C
Int J Oral Maxillofac Surg; 2021 Jun; 50(6):740-745. PubMed ID: 33023802
[TBL] [Abstract][Full Text] [Related]
39. The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma.
Lu SY; Ma MC; Wang MC; Hsue SS
J Formos Med Assoc; 2021 Nov; 120(11):1967-1976. PubMed ID: 33551311
[TBL] [Abstract][Full Text] [Related]
40. Functional Endoscopic Sinus Surgery for Paranasal Sinusitis Originating From a Peri-implantitis-Triggered Infection in the Augmented Maxilla: A Case Report.
Park WB; Kim YJ; Herr Y; Lim HC
J Oral Implantol; 2020 Aug; 46(4):423-429. PubMed ID: 33031546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
